Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7610040

Concept 2022-01-01 to
2022-03-31
As at
2022-03-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
554,650,000 JPY
2,017,529,000 JPY
231,278,000 JPY
Ordinary profit (loss)
4,576,000 JPY
-522,992,000 JPY
-284,055,000 JPY
Profit (loss) attributable to owners of parent
-15,104,000 JPY
-534,474,000 JPY
-286,331,000 JPY
Comprehensive income
31,390,000 JPY
-510,976,000 JPY
-273,630,000 JPY
Net assets
4,540,757,000 JPY
4,315,572,000 JPY
3,550,380,000 JPY
Total assets
5,355,256,000 JPY
5,432,560,000 JPY
4,228,189,000 JPY
Basic earnings (loss) per share
-1.12
-42.10
-23.09
Diluted earnings per share
Equity-to-asset ratio
0.846 xbrli:pure
0.793 xbrli:pure
0.839 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.